Eurocan 2016

Prof Schadendorf talks to ecancertv at the EurocanPlatform Summer School on translational research about his work looking at skin cancer with a focus on malignant melanoma. He explains how chemotherapy is no longer always necessary with the advent of targeted therapies.

Prof Brenner talks to ecancertv at the EurocanPlatform Summer School on translational research about the uses of adoptive cell therapy. In particular, he explains his work looking at the use of T cells to fight lymphoma.

Prof Trumpp talks to ecancertv at the EurocanPlatform Summer School on translational research about the involvement of stem cells in cancer diseases and resistance. In particular, his work has looked at pancreatic cancer.

Dr Vivanco talks to ecancertv at the EurocanPlatform Summer School on translational research about the functions of protein, particularly the kinase Akt which promotes cancer cell survival. The aim is to develop drugs that target these kinases to prevent them from helping cancer cells proliferate, he says. He also discusses the Summer School and why it is so beneficial.

Prof Børresen-Dale talks to ecancertv at the EurocanPlatform Summer School on translational research about the benefits of the event. In particular, she stresses the importance of multiprofessionality — of bringing people from many different fields together to collaborate.

Dr Brady talks to ecancertv at the EurocanPlatform Summer School on translational research about his work looking at blood-borne biomarkers. In particular, he explains how they hope to be able to detect cancer via blood tests.

Prof Schilsky talks to ecancertv at the EurocanPlatform Summer School on translational research about the merits of the course. He stresses the need to bring different perspectives together in order to tackle cancer and comments extremely positively on the potential of the students that attended.

Prof Calvo talks to ecancertv at the EurocanPlatform Summer School on translational research about how a European consortium can help accelerate cancer research to improve clinical practice and patient outcomes. The main basis for the consortium is data sharing between institutes, he says, and currently comprises 6 centres. He explains how the ultimate vision for the project is a 'virtual Europe' of openness and collaboration.

Prof Daniel Mertens and Prof Alexander Schiller of Schiller & Mertens in Jena, Germany, talk to ecancertv at the EurocanPlatform Summer School on translational research about the course they have founded to help researchers to present their work more effectively and deal better with the associated logistics and interpersonal demands of collaborative work.

Dr Nils Brünner talks to ecancertv at the EurocanPlatform Summer School on translational research about his work in translational cancer research and the advice he gives his students.

Dr Shield talks to ecancertv at the EurocanPlatform Summer School on translational research about the differing epidemiological burden of cancer in different parts of the world. By comparing, between countries, the types of cancer that are most prevalent, non-genetic risk factors can be identified such as sun exposure or smoking.